Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Delaware company to open new location
April 2019
SHARING OPTIONS:

WILMINGTON, Del.—The theme of Q1 2019 for Wilmington PharmaTech is growth, as the contract research/manufacturing organization has announced plans to expand its Delaware footprint by hiring up to 139 new employees and investing $18 million to build a state-of-the-science research and manufacturing facility in Newark.
 
“This marks the next wave of growth, positioning Wilmington PharmaTech as the leader in new drug manufacturing in the US,” said company president and CEO Dr. Hui-Yin Harry Li. “This expansion scales up operations and significantly enhances offerings to our clients in API manufacturing and related services. It also expands our portfolio of research, development and potential commercial API services. PharmaTech’s expansion plans fulfill the commitment to growth and its hallmark reputation for excellence for our employees, customers, partners and our community in the state of Delaware.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.